Key result
The LACBES left atrial appendage occluder was successfully implanted in all 7 canines, demonstrating complete neointima formation within 4 months and no device-related complications.
Why the study?
Is the LACBES occluder feasible and safe for left atrial appendage closure in a canine model?
Is the LACBES occluder feasible and safe for left atrial appendage closure in a canine model?
The LACBES occluder demonstrates preclinical feasibility, safety, and complete endothelialization for left atrial appendage closure in a canine model.
Hypothesis-generating for LACBES® in LAA closure; prospective human trials needed before clinical adoption.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2017) studied Preclinical evaluation for Left Atrial Appendage Closure (n=7). LACBES LAA occluder was evaluated on Successful implantation and complete closure. The LACBES left atrial appendage occluder was successfully implanted in all 7 canines, demonstrating complete neointima formation within 4 months and no device-related complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: